Recent Developments in Transvaginal Mesh Litigation
Last updated: September 3, 2026
The big federal pelvic mesh cases have largely wound down. People still look into these products, because pain, erosion, urinary problems and repeat surgery did not wind down with them.
This page covers what happened to those cases, and the question that matters most if you are looking into it now: which product was actually implanted.
This page provides general educational information and does not constitute legal advice.
- The main federal pelvic mesh MDLs are no longer active in the way they once were.
- FDA action in 2019 remains one of the biggest turning points in the transvaginal mesh story.
- People still research these products because complications and product-identification questions continue long after implantation.
- Operative reports, implant stickers, and revision records can still matter a great deal.
What Is Transvaginal Mesh?
Transvaginal mesh is surgical mesh used in operations for pelvic organ prolapse or stress urinary incontinence. Many patients later reported serious problems: the mesh eroding, lasting pain, infection, bleeding, pain during sex, urinary trouble, and surgery to remove or repair it.
What Changed in Recent Years?
The clearest turning point came in 2019. The FDA ordered manufacturers to stop selling surgical mesh intended for transvaginal repair of pelvic organ prolapse in the United States.
That regulatory action was specific to mesh products intended for transvaginal repair of pelvic organ prolapse. It did not mean every mesh-related device in every category was treated the same way, which is why product category and procedure type still matter when people research this subject.
What Happened to the Major Federal Mesh MDLs?
The largest federal pelvic mesh multidistrict litigations were centralized in the Southern District of West Virginia. The major proceedings involving Bard, American Medical Systems, Boston Scientific, Ethicon, and Coloplast are now closed.
The better way to understand the current landscape is that the main centralized federal mesh wave has largely passed. That does not mean every legal issue involving pelvic mesh disappeared at the same moment, but it does mean the largest federal MDL phase is no longer the center of the story.
Where the cases are now
The federal wave is over. The litigation is not. It moved to state courts, and the center of it is New Jersey.
New Jersey runs two coordinated groups of pelvic mesh cases, one for Ethicon products and one for Bard. As of a case management order in mid-2026, the Ethicon group alone had more than 560 active cases. The court has been extending deadlines for evidence-gathering and setting schedules for expert testimony and pretrial motions, which is a court preparing cases to be tried, not winding them down.
New cases are also being filed elsewhere, including Minnesota and Massachusetts, where two of the manufacturers are based.
For scale, the federal proceedings that closed involved more than 107,000 cases, of which more than 75,000 were resolved there. Manufacturers have reportedly paid over $8 billion, and because many settlements are confidential the real figure is likely higher.
If you were implanted with pelvic mesh and had complications, the practical point is that the closure of the federal cases did not close the subject. What matters is which product you had, what your records show, and the filing deadline in your state.
Why Do People Still Research Transvaginal Mesh?
Complications often take years to make sense. People come back to this long after the operation, wanting to know which manufacturer made the device, whether other patients reported the same injuries, and whether their own records say what was used.
In many situations, product identification becomes one of the most important practical issues. That can include the manufacturer name, product name, operative report, implant records, catalog references, and any other documentation that helps connect a procedure to a specific device.
Why Product Identification Still Matters
Most people start with a general question about mesh lawsuits. The practical next step is narrower: work out which product was used. FDA records can help you identify a manufacturer or product family, but pinning down the exact device usually comes from operative reports, implant stickers, hospital records and any paperwork from a later corrective surgery.
What This Means for Readers Today
Knowing the big cases have closed is only part of it. What matters more is why: the FDA action that changed the market, the scale the litigation reached, and the fact that your medical records and the identity of the device still decide what is possible now.
Common Questions People Ask
- Is transvaginal mesh litigation still active?
- Did the FDA remove certain transvaginal mesh products from the market?
- What happened to the major federal mesh MDLs?
- How can someone identify which mesh product was implanted?
- Why do people still research transvaginal mesh years later?
Explore Related Lawsuit Topics
Ready to explore related cases and legal topics? Browse the lawsuit directory or learn how the legal process works.
If you're trying to understand whether this situation may apply to you, you can share a few details below to get started.
Educational purposes only. Submitting this form does not create an attorney-client relationship.
Related Legal Guides
Transvaginal Mesh Lawsuits
Start with the broader overview of mesh injuries, litigation history, and product-identification issues.
Transvaginal Mesh Manufacturers and Public Product Identifiers
Review manufacturers, product families, and public reference points that may help with product research.
How Lawsuits Work
Get a simple overview of how legal claims are investigated, filed, and resolved over time.
Mass Torts
Understand how coordinated proceedings work when many similar claims move through court together.
